Immunohematology Market Set To Grow From $2.69 Billion In 2026 To $3.27 Billion By 2030 At A CAGR Of 5%
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Immunohematology Market Size And Revenue Forecast Through 2030
The immunohematology market has experienced consistent growth over the past several years. From a valuation of $2.56 billion in 2025, it is projected to reach $2.69 billion by 2026, reflecting a compound annual growth rate (CAGR) of 4.9%. This historical expansion has been driven by factors such as the rising incidence of blood disorders, a growing need for secure blood transfusions, the establishment of more blood banks, an increase in the number of diagnostic laboratories, and ongoing improvements in hematology reagents.
The immunohematology sector is anticipated to experience significant expansion over the coming years. By 2030, its market value is projected to reach $3.27 billion, reflecting a compound annual growth rate (CAGR) of 5.0%. This upward trajectory in the forecast period is driven by factors such as progress in analyzer technology, the application of artificial intelligence within lab diagnostics, a growing focus on precision medicine, the incorporation of digital health platforms, and the widening reach of blood screening initiatives. Key developments shaping this period involve cutting-edge blood typing methods, increased automation in immunohematology procedures, customized approaches to transfusion therapy, immunological diagnostics performed at the point of care, and the seamless connection of laboratory information systems.
Download A Free Sample Report For Comprehensive Market Insights:
Immunohematology Market Growth Factors Supporting Long-Term Expansion
The growth of the immunohematology market is being significantly driven by the aging population in the coming years. This demographic trend, defined by a rising share of elderly individuals within a society, creates a high demand for blood-related medical care. Immunohematology plays a critical role in managing transfusion requirements specific to older adults, ensuring the safe administration of blood products and supporting various healthcare procedures for this group. To illustrate, data from January 2024 published by the Population Reference Bureau, a nonprofit organization based in the United States, indicates that the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Furthermore, this age cohort’s proportion of the total US population is forecasted to climb from 17% to 23% over that same interval. Consequently, the aging population is a key factor propelling the immunohematology market forward.
Immunohematology Market Segment Analysis: What Are The Major Market Categories?
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum
Immunohematology Market Industry Trends Shaping Future Revenue Growth
Key players in the immunohematology field are directing their efforts toward creating advanced diagnostic tools, including soluble recombinant proteins engineered to counteract the disruptive effects of the cancer drug daratumumab on testing. Such proteins are generated via recombinant DNA methods, preserving their correct structure and biological activity when dissolved in a host system or solution, which supports their utility in both research and medical contexts. As an example, in November 2023, Grifols, S.A., a pharmaceutical firm based in Spain, introduced its Grifols sCD38 product, marking the debut of a soluble recombinant protein in the market. This innovation was crafted to mitigate the obstacles presented by daratumumab in critical blood compatibility assessments for transfusions. Tailored specifically for individuals with multiple myeloma, the solution prevents daratumumab from binding to CD38 sites on red blood cells, thereby enabling accurate results in pre-transfusion evaluations. By streamlining the steps involved in screening, identification, and crossmatching, the Grifols sCD38 solution improves transfusion procedures and reduces delays in delivering essential blood products to patients.
Immunohematology Market Leading Companies Driving Competitive Growth
Major companies operating in the immunohematology market are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
Access The Complete Immunohematology Market Report:
Immunohematology Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the immunohematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
